Immunodiagnostic Systems Holdings PLC (IDS) develops, manufactures, and markets immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. Its immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in complementary fields.